Trial reportBMC psychiatry2026
Effect of group reminiscence therapy combined with cognitive restructuring on middle-aged and elderly participants with schizophrenia.
Trial report in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the effectiveness of group reminiscence therapy combined with cognitive restructuring in the nursing care of middle-aged and elderly people with schizophrenia.
methodsUsing a convenience sampling approach, 70 hospitalized middle-aged and elderly participants with schizophrenia were selected from a tertiary psychiatric hospital in Hefei, Anhui Province, during the period from March 2023 to March 2024. A random assignment placed 35 participants in the control group and 35 in the intervention group. All participants maintained their stable, pre-existing antipsychotic medication regimens throughout the study period, with no changes initiated for research purposes. While the control group received conventional rehabilitation nursing, the intervention group received an additional intervention of group reminiscence therapy combined with cognitive restructuring on top of routine care. The intervention lasted for 8 weeks. The Positive and Negative Syndrome Scale (PANSS) was used to assess psychiatric symptom severity before and after the intervention. The Montreal Cognitive Assessment (MoCA) was used to assess cognitive function, and the Schizophrenia Quality of Life Scale (SQLS) was employed to evaluate quality of life.
resultsRepeated-measures ANOVA revealed significant Group × Time interaction effects for PANSS total score (F(1,68) = 23.96, p < 0.001), MoCA (F(1,68) = 9.01, p = 0.004), and SQLS (F(1,68) = 15.07, p < 0.001). Simple effects analyses showed that after the 8-week intervention, the intervention group achieved significantly greater reductions in PANSS total score and SQLS score, as well as a significantly greater increase in MoCA score, compared to the control group (all p < 0.05).
conclusionGroup reminiscence therapy combined with cognitive restructuring can effectively alleviate psychiatric symptoms, enhance cognitive function, and improve the quality of life in middle-aged and elderly people with schizophrenia. This combined intervention also contributes to psychological activation and facilitates psychiatric rehabilitation. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.